As of Feb 17
| +0.12 / +2.80%|
The 1 analysts offering 12-month price forecasts for TapImmune Inc have a median target of 27.00, with a high estimate of 27.00 and a low estimate of 27.00. The median estimate represents a +513.64% increase from the last price of 4.40.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.